siRNA takes a jab at hypertension.
Med
; 5(5): 383-385, 2024 May 10.
Article
em En
| MEDLINE
| ID: mdl-38733971
ABSTRACT
Hypertension is a modifiable risk factor for cardiovascular disease, the leading cause of death worldwide, yet most US adults with hypertension do not meet goal blood pressure. KARDIA-1 demonstrates the efficacy of zilebesiran, a subcutaneously administered small interfering RNA, for lowering blood pressure, presenting a novel treatment option for this deadly disease.1.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
RNA Interferente Pequeno
/
Hipertensão
Limite:
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article